Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Chee Kong Choo currently holds 630,324 shares of CytoMed Therapeutics Ltd (GDTC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Chee Kong Choo has been a net buyer of GDTC stock. They have purchased $428.8K and sold $0 worth of shares.
Chee Kong Choo's most recent insider trade was on Jul 20, 2026, when they purchased 100,000 shares at $1.50 per share.
Chee Kong Choo serves as Executive at CytoMed Therapeutics Ltd (GDTC). They have executed 3 insider transactions totaling $428.8K over their tenure at the company.
Chee Kong Choo holds the position of Executive at CytoMed Therapeutics Ltd, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 1 years and currently hold a stake valued at $0.
Chee Kong Choo has shown a buying trading pattern, with $428.8K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Chee Kong Choo was on Jul 20, 2026, when they purchased $150.0K worth of GDTC shares. This transaction involved 100,000 shares at $1.50 per share.
Chee Kong Choo currently owns 630,324 shares of CytoMed Therapeutics Ltd (GDTC), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Chee Kong Choo's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Chee Kong Choo has 3 Form 4 filings on record as an insider at CytoMed Therapeutics Ltd.
Set alerts for Chee Kong Choo and 40,000+ other insiders.